Components of the cultivated red seaweed Chondrus crispus enhance the immune response of Caenorhabditis elegans to Pseudomonas aeruginosa through the pmk-1, daf-2/daf-16, and skn-1 pathways

Applied and Environmental Microbiology

Volumn 79, Issue 23, 2013, Pages 7343-7350

  Liu, Jinghua ^a   Hafting, Jeff ^b   Critchley, Alan T ^b   Banskota, Arjun H ^c   Prithiviraj, Balakrishnan ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Acadian Seaplants Limited   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITIES; BENEFICIAL EFFECTS; BIOACTIVE COMPOUNDS; CAENORHABDITIS ELEGANS; HOST IMMUNE RESPONSE; KAPPA CARRAGEENAN; PSEUDOMONAS AERUGINOSA; VIRULENCE FACTORS;

ANIMALS; BACTERIA; GENE EXPRESSION; HEALTH; SEAWEED;

IMMUNE SYSTEM;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOACTIVITY; CULTIVATION; GENE EXPRESSION; GROWTH RATE; IMMUNE RESPONSE; IMMUNITY; MACROALGA; NEMATODE; SEAWEED;

ANTIINFECTIVE AGENT; CAENORHABDITIS ELEGANS PROTEIN; DAF 16 PROTEIN, C ELEGANS; DAF 2 PROTEIN, C ELEGANS; DAF-16 PROTEIN, C ELEGANS; DAF-2 PROTEIN, C ELEGANS; DNA BINDING PROTEIN; IMMUNOLOGIC FACTOR; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PMK 1 PROTEIN, C ELEGANS; PMK-1 PROTEIN, C ELEGANS; SKN 1 PROTEIN, C ELEGANS; SKN-1 PROTEIN, C ELEGANS; TRANSCRIPTION FACTOR; VIRULENCE FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CAENORHABDITIS ELEGANS; CHEMISTRY; CHONDRUS; DRUG EFFECT; IMMUNOLOGY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

ANIMALS; ANTI-BACTERIAL AGENTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHONDRUS; DNA-BINDING PROTEINS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RECEPTOR, INSULIN; TRANSCRIPTION FACTORS; VIRULENCE FACTORS;

EID: 84888268471     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01927-13     Document Type: Article

References (46)

1. Kumar CS, Ganesan P, Suresh PV, Bhaskar N. 2008. Seaweeds as a source of nutritionally beneficial compounds-a review. J. Food Sci. Technol. 45:1-13.
2. Holdt SL, Kraan S. 2011. Bioactive compounds in seaweed: functional food applications and legislation. J. Appl. Phycol. 23:543-597.
3. Okai Y, Higashi-Okai K, Yano Y, Otani S. 1996. Identification of antimutagenic substances in an extract of edible red alga, Porphyra tenera (Asakusa-nori). Cancer Lett. 100:235-240.
4. Maruyama H, Watanabe K, Yamamoto I. 1991. Effect of dietary kelp on lipid peroxidation and glutathione per-oxidase activity in livers of rats given breast carcinogen DMBA. Nutr. Cancer 15:221-228.
5. Yang YJ, Nam S-J, Kong G, Kim MK. 2010. A case-control study on seaweed consumption and the risk of breast cancer. Br. J. Nutr. 103:1345-1353.
6. Chopin T, Gallant T, Davison I. 1995. Phosphorus and nitrogen nutrition in Chondrus crispus (Rhodophyta): effects on total phosphorus and nitrogen content, carrageenan production, and photosynthetic pigments and metabolism. J. Phycol. 31:283-293.
7. Skoler-KarpoffS, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, Kock AD, Cassim N, Palanee T. 2008. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 372:1977-1987.
8. Luescher-Mattli M. 2003. Algae, a possible source for new drugs in the treatment of HIV and other viral diseases. Curr. Med. Chem. 2:219-225.
9. Zhou G, Sheng W, Yao W, Wang C. 2006. Effect of low molecular lambda-carrageenan from Chondrus ocellatus on anti-tumor H-22 activity of 5-Fu. Pharmacol. Res. 53:129-134.
10. Shiau S-Y, Chang GW. 1986. Effects of certain dietary fibers on apparent permeability of the rat intestine. J. Nutr. 116:223-232.
11. Wood RE. 1976. Pseudomonas: the compromised host. Hosp. Pract. 11:91-100.
12. Tan MW, Rahme LG, Sternberg J, Tompkins RG, Ausubel FM. 1999. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc. Natl. Acad. Sci. U. S. A. 96:2408-2413.
13. Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G, Thomashow LS. 2001. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J. Bacteriol. 21:6454-6465.
14. Smith RS, Iglewski BH. 2003. P. aeruginosa quorum-sensing systems and virulence. Curr. Opin. Microbiol. 6:56-60.
15. Gander S. 1996. Bacterial biofilms: resistance to anti-microbial agents. J. Antimicrob. Chemother. 37:1047-1050.
16. Juhas M, Eberl L, Tummler B. 2005. Quorum sensing: the power of cooperation in the world of Pseudomonas. Environ. Microbiol. 7:459-471.
17. Ewbank JJ. 23 January 2006. Signaling in the immune response. In The C. elegans Research Community (ed), WormBook. doi: 10.1895/wormbook.1.83.1. http://www.wormbook.org/chapters/www_signalingimmuneresponse/signalingimmuneresponse.html.
18. Mochii M, Yoshida S, Morita K, Kohara Y, Ueno N. 1999. Identification of transforming growth factor-regulated genes in Caenorhabditis elegans by differential hybridization of arrayed cDNAs. Proc. Natl. Acad. Sci. U. S. A. 96:15020-15025.
19. Gravato-Nobre MJ, Hodgkin J. 2005. Caenorhabditis elegans as a model for innate immunity to pathogens. Cell. Microbiol. 7:741-751.
20. Estes KA, Dunbar TL, Powell JR, Ausubel FM, Troemel ER. 2010. bZIP transcription factor zip-2 mediates an early response to Pseudomonas aeruginosa infection in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 107:2153-2158.
21. Kandasamy S, Khan W, Evans F, Critchley AT, Prithiviraj B. 2012. Tasco®: a product of Ascophyllum nodosum enhances immune response of Caenorhabditis elegans against Pseudomonas aeruginosa infection. Mar. Drugs 10:84-105.
22. Sulston J, Hodgkin J. 1988. Methods, p 587. In Wood WB (ed), The nematode Caenorhabditis elegans. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. Dow JM, Clarke BR, Milligan DE, Tang JL, Daniels MJ. 1990. Extracellular proteases from Xanthomonas campestris pv. campestris, the black rot pathogen. Appl. Environ. Microbiol. 56:2994-2998.
24. Howe TR, Iglewski BH. 1984. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect. Immun. 43:1058-1063.
25. Ohman DE, Cryz SJ, Iglewski BH. 1980. Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J. Bacteriol. 142:836-842.
26. Sadasivam S, Manickam A. 1996. Biochemical methods, 1st ed. New Age International Ltd., New Delhi, India.
27. Miller RL, Higgins VJ. 1970. Association of cyanide with infection of birdfoot trefoil Stemphylium loti. Phytopathology 60:104-110.
28. Denervaud V, Tuquoc P, Blanc D, Favre-Bonte S, Krishnapillai V, Remmann C, Heas D, Delden CV. 2004. Characterization of cell-to-cell signaling-deficient Pseudomonas aeruginosa strains colonizing intubated patients. J. Clin. Microbiol. 42:554-562.
29. Reeves M, Pine L, Neilands JB, Bullows A. 1983. Absence of siderophore activity in Legionella species grown in iron-deficient media. J. Bacteriol. 154:324-329.
30. Shanks RMQ, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA. 2005. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 73:4596-4606.
31. Craigie JS, Leigh C. 1978. Carrageenans and agars, p 109-131. In Hellebust JA, Craigie JS (ed), Handbook of phycological methods: physiological and biochemical methods. Cambridge University Press, New York, NY.
32. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM. 2006. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2:e183. doi:10.1371/journal.pgen.0020183.
33. Evans EA, Kawli T, Tan MW. 2008. Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog. 4:e1000175. doi:10.1371/journal.ppat.1000175.
34. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902.
35. Darby C, Cosma CL, Thomas JH, Manoil C. 1999. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 96:15202-15207.
36. Jha B, Kavita K, Westphal J, Hartmann A, Schmitt-Kopplin P. 2013. Quorum sensing inhibition by Asparagopsis taxiformis, a marine macroalga: separation of the compound that interrupts bacterial communication. Mar. Drugs 11:253-265.
37. Givskov M, DeNys R, Manefield M, Gram L, Maximilien R, Eberl L, Molin S, Steinberg P, Kjelleberg S. 1996. Eukaryotic interference with homoserine lactone-mediated prokaryotic signaling. J. Bacteriol. 178:6618-6622.
38. Miyata S, Begun J, Troemel ER, Ausubel FM. 2008. DAF-16-dependent suppression of immunity during reproduction in Caenorhabditis elegans. Genetics 178:903-918.
39. Stroeher VL, Kennedy BP, Millen KJ, Schroeder DF, Hawkins MG. 1994. DNA-protein interactions in the Caenorhabditis elegans embryo: oocyte and embryonic factors that bind to the promoter of the gut-specific ges-1 gene. Dev. Biol. 163:367-380.
40. Mallo GV, Kurz CL, Couillault C, Pujol N, Granjeaud S. 2002. Inducible antibacterial defense system in C. elegans. Curr. Biol. 12:1209-1214.
41. O'Rourke D, Baban D, Demidova M, Mott R, Hodgkin J. 2006. Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilum. Genome Res. 16:1005-1016.
42. Apidianakis Y, Mindrinos MN, Xiao W, Lau GW, Baldini RL. 2005. Profiling early infection responses: Pseudomonas aeruginosa eludes host defenses by suppressing antimicrobial peptide gene expression. Proc. Natl. Acad. Sci. U. S. A. 102:2573-2578.
43. Alper S, McBride SJ, Lackford B, Freedman JH, Schwartz DA. 2007. Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol. Cell. Biol. 27:5544-5553.
44. Tobacman JK. 2001. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health Perspect. 109:983-994.
45. Weiner ML, Nuber D, Blakemore WR, Harriman JF, Cohen SM. 2007. A 90-day dietary study on kappa carrageenan with emphasis on the gastrointestinal tract. Food Chem. Toxicol. 45:98-106.
46. Sangha JS, Ravichandran S, Prithiviraj K, Critchley AT, Prithiviraj B. 2010. Sulfated macroalgal polysaccharide iota-carrageenan induces resistance against Sclerotinia sclerotiorum in Arabidopsis thaliana, whereas lambda-carrageenan enhances susceptibility. Physiol. Mol. Plant Pathol. 75:38-45.